Pages that link to "Q33851157"
Jump to navigation
Jump to search
The following pages link to Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance (Q33851157):
Displaying 10 items.
- Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma (Q35775787) (← links)
- Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis (Q35997896) (← links)
- Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma. (Q36863127) (← links)
- Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway (Q37701508) (← links)
- Regulation of hepatocyte identity and quiescence. (Q38531851) (← links)
- Gankyrin regulates cell signaling network (Q38714564) (← links)
- Gankyrin as a potential therapeutic target for cancer (Q39319386) (← links)
- Upregulation of PSMD10 caused by the JMJD2A histone demethylase (Q41615123) (← links)
- MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression (Q49796436) (← links)
- The Oncoprotein Gankyrin/PSMD10 as a Target of Cancer Therapy (Q90429861) (← links)